| 12459967 |
Modulators of 5′-nucleotidase, ecto and the use thereof |
Laurent P. Debien, Juan C. Jaen, Jaroslaw Kalisiak, Kenneth V. Lawson, Manmohan Reddy Leleti +5 more |
2025-11-04 |
|
| 12433836 |
Parenterally administered immune enhancing drugs |
Juan C. Jaen, Jenna Leigh Jeffrey, Lingtao Jin, Jaroslaw Kalisiak, Joyson Karakunnel +2 more |
2025-10-07 |
|
| 12421195 |
Amorphous and crystalline forms of IDO inhibitors |
Hilary Plake Beck, Maksim Osipov, Maureen Kay Reilly, Hunter Paul Shunatona, James Ross Walker +5 more |
2025-09-23 |
|
| 12410170 |
2,3,5-trisubstituted pyrazolo[1,5-A]pyrimidine compounds |
Joel Worley Beatty, Samuel Lawrie Drew, Jeremy Thomas Andre Fournier, Jenna Leigh Jeffrey, Kenneth V. Lawson +7 more |
2025-09-09 |
|
| 12226425 |
Inhibitors of ARG1 and/or ARG2 |
Joel Worley Beatty, Eric Newcomb, Brandon Reid Rosen, Yongli Su, Anh Thu Tran +8 more |
2025-02-18 |
|
| 12195447 |
Azolopyrimidine for the treatment of cancer-related disorders |
Joel Worley Beatty, Laurent P. Debien, Jenna Leigh Jeffrey, Manmohan Reddy Leleti, Debashis Mandal +4 more |
2025-01-14 |
|
| 12195482 |
Compounds as inhibitors of AXL |
Joel Worley Beatty, Corinne Nicole Foley, Balint Gal, Manjunath Lamani, Manmohan Reddy Leleti +3 more |
2025-01-14 |
|
| 12168023 |
Inhibitors of adenosine 5′-nucleotidase |
Laurent P. Debien, Jaroslaw Kalisiak, Kenneth V. Lawson, Manmohan Reddy Leleti, Erick Allen Lindsey +4 more |
2024-12-17 |
$19,871,000 |
| 12139475 |
2-oxindole compounds |
Xi Chen, Dean R. Dragoli, Pingchen Fan, Manmohan Reddy Leleti, Rebecca M. Lui +6 more |
2024-11-12 |
|
| 12103907 |
Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha |
Joel Worley Beatty, Samuel Lawrie Drew, Matthew Epplin, Jeremy Thomas Andre Fournier, Balint Gal +19 more |
2024-10-01 |
$18,952,000 |
| 12071411 |
Inhibitors of HIF-2α and methods of use thereof |
Joel Worley Beatty, Samuel Lawrie Drew, Matthew Epplin, Jeremy Thomas Andre Fournier, Balint Gal +9 more |
2024-08-27 |
$22,048,000 |
| 12064433 |
Pyridone A2R antagonists |
Manmohan Reddy Leleti, Debashis Mandal, Dillon Harding Miles, Brandon Reid Rosen, Ehesan Ul Sharif |
2024-08-20 |
$23,865,000 |
| 12054484 |
Substituted tetrahydropyrans as CCR2 modulators |
Junfa Fan, Jaroslaw Kalisiak, Rebecca M. Lui, Venkat Reddy Mali, Jeffrey P. McMahon +3 more |
2024-08-06 |
|
| 11993584 |
Solid forms of an azolopyrimidine compound |
Jenna Leigh Jeffrey, Manmohan Reddy Leleti, Dillon Harding Miles |
2024-05-28 |
$19,631,000 |
| 11951214 |
Capsule formulations |
Manmohan Reddy Leleti |
2024-04-09 |
|
| 11932601 |
Immunoregulatory agents |
Hilary Plake Beck, Juan C. Jaen, Maksim Osipov, Maureen Kay Reilly, Hunter Paul Shunatona +5 more |
2024-03-19 |
|
| 11931343 |
CD73 inhibitors |
Joel Worley Beatty, Laurent P. Debien, Samuel Lawrie Drew, Jeremy Thomas Andre Fournier, Rebecca Grange +9 more |
2024-03-19 |
$24,136,000 |
| 11919863 |
Substituted quinolinylcyclohexylpropanamide compounds and improved methods for their preparation |
Albert J. DelMonte, Benjamin M. Cohen, Kenneth Joseph FRAUNHOFFER, Sergei Kolotuchin, Francisco Gonzalez-Bobes +12 more |
2024-03-05 |
$181,333,000 |
| 11884654 |
Substituted anilines as CCR(4) antagonists |
Trevor T. Charvat, Junfa Fan, Christopher W. Lange, Manmohan Reddy Leleti, Yandong Li +4 more |
2024-01-30 |
|
| 11845729 |
Processes and intermediates in the preparation of C5aR antagonists |
Pingchen Fan, Jaroslaw Kalisiak, Antoni Krasinski, Rebecca M. Lui, Sreenivas Punna +2 more |
2023-12-19 |
|
| 11834452 |
CXCR7 antagonists |
Junfa Fan, Antoni Krasinski, Christopher W. Lange, Rebecca M. Lui, Jeffrey P. McMahon +2 more |
2023-12-05 |
|
| 11787762 |
Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha |
Joel Worley Beatty, Samuel Lawrie Drew, Matthew Epplin, Jeremy Thomas Andre Fournier, Balint Gal +19 more |
2023-10-17 |
$20,754,000 |
| 11759454 |
Diazole lactams |
Xi Chen, Pingchen Fan, Yandong Li, Viengkham Malathong, Sreenivas Punna +3 more |
2023-09-19 |
|
| 11667662 |
Modulators of 5′-nucleotidase, ecto and the use thereof |
Laurent P. Debien, Juan C. Jaen, Jaroslaw Kalisiak, Kenneth V. Lawson, Manmohan Reddy Leleti +5 more |
2023-06-06 |
$26,012,000 |
| 11633416 |
Oral formulations of CD73 compounds |
Kenneth V. Lawson, Manmohan Reddy Leleti |
2023-04-25 |
$22,893,000 |
